Article: Should tumour infiltrating lymphocytes and PIK3Ca mutation be added as markers to the histology report for breast cancer?

3.03

SKU: product-article-10961 Category:

Description

Should tumour infiltrating lymphocytes and PIK3Ca mutation be added as markers to the histology report for breast cancer?

Reviews

There are no reviews yet.

Be the first to review “Article: Should tumour infiltrating lymphocytes and PIK3Ca mutation be added as markers to the histology report for breast cancer?”